» Articles » PMID: 30773344

Case-non-case Studies: Principle, Methods, Bias and Interpretation

Overview
Journal Therapie
Specialty Pharmacology
Date 2019 Feb 19
PMID 30773344
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Case-non-case studies are among the methods used to assess drug safety by analyzing the disproportionality of adverse drug reaction reports in pharmacovigilance databases. First used in the 1980s, the last few decades have seen a significant increase in the use of this study design. The principle of case-non-case studies is to compare the drug exposure of cases of an adverse reaction of interest with that of cases with other reported reactions and called "non-cases". Their results are presented in the form of reporting odds ratio (ROR), the interpretation of which makes it possible to highlight pharmacovigilance signals. This article describes the principle of case-non-case studies, the calculation method of the ROR and its confidence interval, the different analytical modalities and how to interpret its results with regard to the advantages and limitations of this type of study.

Citing Articles

Hemorrhage risk associated with triple antithrombotic therapy: a focused real-world pharmacovigilance disproportional analysis study.

Sridharan K, Sivaramakrishnan G BMC Cardiovasc Disord. 2025; 25(1):180.

PMID: 40087557 DOI: 10.1186/s12872-025-04510-4.


Drug-associated gingival disorders: a retrospective pharmacovigilance assessment using disproportionality analysis.

Sridharan K, Sivaramakrishnan G BDJ Open. 2025; 11(1):24.

PMID: 40069171 PMC: 11897221. DOI: 10.1038/s41405-024-00291-8.


Hypertension associated with serotonin reuptake inhibitors: A new analysis in the WHO pharmacovigilance database and examination of dose-dependency.

Chretien B, Rabiaza A, Kazuki N, Fedrizzi S, Sassier M, Dolladille C PLoS One. 2025; 20(3):e0317841.

PMID: 40053562 PMC: 11888134. DOI: 10.1371/journal.pone.0317841.


Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case/non-case malformed study.

Saint-Lary L, Beau A, Sommet A, Leroy V, Loane M, Cavero-Carbonell C Eur J Clin Pharmacol. 2025; .

PMID: 40011239 DOI: 10.1007/s00228-025-03814-w.


Amlodipine-Associated Angioedema: An Integrated Pharmacovigilance Assessment Using Disproportionality and Interaction Analysis and Case Reviews.

Sridharan K, Sivaramakrishnan G J Clin Med. 2025; 14(4).

PMID: 40004629 PMC: 11856106. DOI: 10.3390/jcm14041097.